THE WHAT L’Oréal USA has announced the appointment of Sanford Browne as President of Research & Innovation for the North America zone.
THE DETAILS Browne will report to Stéphane Rinderknech, Chief Executive Officer of L’Oréal USA and President of North America Zone, as well as Barbara Lavernos, Deputy Chief Executive Officer in charge of Research, Innovation and Technology.
He will also serve as a member of the L’Oréal USA’s Management Committee, as well as a member of the Global R&I Management Committee.
Browne takes on the role following his position as Senior Vice President for R&I for L’Oréal’s Asia Pacific zone, where he helped build a complete R&I division across the Zone, including the research Hubs of China and Japan, along with Seoul, Bangalore and Singapore.
THE WHY The executive was lauded for his contribution to developing local research in L’Oréal’s Asia Pacific zone and for being a major architect of research and strategic partnerships.
Stéphane Rinderknech, CEO, L’Oréal USA and President, North America Zone, said, “Sanford brings with him an extensive knowledge of the expectations and beauty rituals of consumers, a track record of delivering on consumer-centric product innovation, and a drive to build our innovation capabilities through external strategic partnerships. His mission will be to strengthen our North American Research and Innovation hub and enable us to seize the consumer shifts that are key to our future success.”
Aesthetic injectable companies refer to businesses or companies that specialize in manufacturing, distributing, or providing aesthetic injectable products and services. These companies focus on developing and supplying injectable substances used for cosmetic purposes, typically administered by qualified medical professionals. Aesthetic injectable companies play a crucial role in the field of aesthetic medicine and cosmetic dermatology by offering a variety of injectable products designed to enhance facial features, reduce wrinkles, and improve overall skin appearance.
Key aspects of aesthetic injectable companies include:
-
Product Development: These companies research, develop, and manufacture aesthetic injectables such as dermal fillers, botulinum toxins (e.g., Botox), collagen stimulators, and other specialized formulations. They often innovate new products to meet evolving market demands and technological advancements.
-
Distribution and Sales: Aesthetic injectable companies distribute their products through authorized channels, including healthcare providers, medical spas, and aesthetic clinics. They may also sell directly to licensed professionals who administer these treatments.
-
Regulatory Compliance: Due to the medical nature of their products, aesthetic injectable companies adhere to strict regulatory guidelines and obtain necessary approvals from health authorities (e.g., FDA in the United States) to ensure safety, efficacy, and quality standards.
-
Training and Support: Many companies provide training and educational support to healthcare professionals on the proper use, administration techniques, and safety protocols associated with their injectable products. This ensures that practitioners can deliver treatments effectively and safely.
-
Customer Support: Aesthetic injectable companies offer customer support services to healthcare providers and consumers, addressing inquiries, providing product information, and assisting with product usage and troubleshooting.
